VEGFA and osteosarcoma: In osteosarcoma studies, it has been found that some biomarkers related to the NF-κB signaling pathway, such as the nuclear expression level of the NF-κB subunit and the expression level of target genes such as Cyclin D1 and VEGF, are closely related to patient prognosis and response to therapy.